Sandrine Silvente-Poirot
7PUBLICATIONS
19CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Mar 10, 2026
Selective DHCR7 inhibition versus AEBS modulation: Mechanistic implications for tamoxifen effects in AML.Marc Poirot, Philippe de Medina, Sandrine Silvente-Poirot
|Jan 31, 2026
The Phospholipid Bis(monoacylglycero)Phosphate Confers Antitumour Immunogenicity to Exosomes Secreted by Dendrogenin A, Which Activates Its Biosynthesis in Tumour Cells.Julio Buñay, Michel Record, Philippe de Medina
|Sep 05, 2022
Targeting NR1H/liver X receptor with dendrogenin A differentiates tumor cells to activate a new secretory pathway releasing immunogenic anti-tumor vesicles enriched in LC3-II-associated exosomes.Philippe de Medina, Julio Bunay, Marc Poirot
|Apr 12, 2022
Targeting the liver X receptor with dendrogenin A differentiates tumour cells to secrete immunogenic exosome-enriched vesicles.Michel Record, Mehdi Attia, Kevin Carayon
|Mar 17, 2021
Neutral Sphingomyelinase 2 Heightens Anti-Melanoma Immune Responses and Anti-PD-1 Therapy Efficacy.Anne Montfort, Florie Bertrand, Julia Rochotte
|Jul 23, 2020
The 5,6-epoxycholesterol metabolic pathway in breast cancer: Emergence of new pharmacological targets.Philippe de Medina, Khadijetou Diallo, Emilie Huc-Claustre
Pageof 2
Frequent Collaborators
6 joint publications
Marc Poirot
3 joint publications
Philippe de Medina
3 joint publications
Julio Bunay
3 joint publications
Michel Record
1 joint publications
Thomas Filleron
1 joint publications
Joëlle Riond
1 joint publications
Gerhard Liebisch
1 joint publications
Christopher J Clarke
1 joint publications
Nilton De França Junior
1 joint publications
Pierre Brousset
